The Food and Drug Administration, which had initially rejected the application, finally gave the company the green light
Neuralink, Elon Musk’s brain-implant company, said on Thursday it had received a green light from the US Food and Drug Administration (FDA) to kickstart its first in-human clinical study, a critical milestone after earlier struggles to gain approval.
Musk has predicted on at least four occasions since 2019 that his medical device company would begin human trials for a brain implant to treat severe conditions such as paralysis and blindness.
About Author
More Stories
Esports are booming in Africa – but can its infrastructure keep pace?
‘Security through obscurity’: the Swedish cabin on the frontline of a possible hybrid war
Man who falsely claimed to be bitcoin creator sentenced for continuing to sue developers